One of two chondrocyte-expressed isoforms of cartilage intermediate-layer protein functions as an insulin-like growth factor 1 antagonist

被引:55
作者
Johnson, K
Farley, D
Hu, SL
Terkeltaub, R
机构
[1] Dept Vet Adm Med Ctr, La Jolla, CA 92161 USA
[2] Univ Calif San Diego, San Diego, CA 92103 USA
[3] Novartis Pharmaceut, Summit, NJ USA
来源
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 05期
关键词
D O I
10.1002/art.10927
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Aging and osteoarthritic (OA) cartilage commonly demonstrate enhanced expression of the large, transforming growth factor beta (TGFbeta)-inducible glycoprotein cartilage intermediate-layer protein (CILP) as well as enhanced extracellular inorganic pyrophosphate (PPi) that promotes the deposition of calcium pyrophosphate dihydrate crystals. In normal chondrocytes, TGFbeta induces elevated chondrocyte extracellular PPi. Insulin-like growth factor 1 (IGF-1) normally blocks this response and reduces extracellular PPi. However, chondrocyte resistance to IGF-1 is observed in OA and aging. Because CILP was reported to chromatographically fractionate with PPi-generating nucleotide pyrophosphatase phosphodiesterase (NPP). activity, it has been broadly assumed that CILP itself has NPP activity. Our objective was to directly define CILP functions and their relationship to IGF-1 in chondrocytes. Methods. Using primary cultures of articular chondrocytes from the knee, we defined the function of the previously described CILP (CILP-1) and of a recently described 50.6% identical protein that we designated the CILP-2 isoform. Results. Both CILP isoforms were constitutively expressed by primary cultured articular chondrocytes, but only CILP-I expression was detectable in cultured knee meniscal cartilage cells. Neither CILP isoform had intrinsic NPP activity. But CILP-1 blocked the ability of IGF-1 to decrease extracellular PPi, an activity specific for the CILP-1 N-terminal domain. The CILP-1 N-terminal domain also suppressed IGF-1-induced (but not TGFbeta-induced) proliferation and sulfated proteoglycan, synthesis, and it inhibited ligand-induced IGF-1 receptor autophosphorylation. Conclusion. Two CILP isoforms are differentially expressed by chondrocytes. Neither CILP isoform exhibits PPi-generating NPP activity. But, increased expression of CILP-1, via N-terminal domain-mediated inhibitory effects of CILP-1 on chondrocyte IGF-1 responsiveness, could impair chondrocyte growth and matrix repair and indirectly promote PPi supersaturation in aging and OA cartilage.
引用
收藏
页码:1302 / 1314
页数:13
相关论文
共 60 条
[21]  
Johnson K, 2001, ARTHRITIS RHEUM, V44, P1071, DOI 10.1002/1529-0131(200105)44:5<1071::AID-ANR187>3.0.CO
[22]  
2-3
[23]  
JOHNSON K, 2000, AM J PHYSIOL-CELL PH, V269, pR1365
[24]  
Loeser RF, 2000, ARTHRITIS RHEUM, V43, P2110, DOI 10.1002/1529-0131(200009)43:9<2110::AID-ANR23>3.0.CO
[25]  
2-U
[26]  
Loeser RF, 2000, ARTHRITIS RHEUM-US, V43, P1552, DOI 10.1002/1529-0131(200007)43:7<1552::AID-ANR20>3.3.CO
[27]  
2-N
[28]   A novel cartilage protein (CILP) present in the mid-zone of human articular cartilage increases with age [J].
Lorenzo, P ;
Bayliss, MT ;
Heinegård, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (36) :23463-23468
[29]   The human CILP gene:: exon/intron organization and chromosomal mapping [J].
Lorenzo, P ;
Åman, P ;
Sommarin, Y ;
Heinegård, D .
MATRIX BIOLOGY, 1999, 18 (05) :445-454
[30]   Cloning and deduced amino acid sequence of a novel cartilage protein (CILP) identifies a preform including a nucleotide pyrophosphohydrolase [J].
Lorenzo, P ;
Neame, P ;
Sommarin, Y ;
Heinegård, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (36) :23469-23475